• Keep investing consistently in stocks rather than trying to time a market peak; elevated valuations do not predict when a correction will occur.
• Review portfolio concentration: the S&P 500 is heavily weighted toward a few large companies, so diversify across asset classes and international markets.
• Reduce leverage if debt could force you to sell during a downturn, and assess whether any single holding or asset class dominates your portfolio.
• If you own a business and are considering a sale, test interest from multiple credible buyers and prepare strong deal materials; high valuations may favor sellers, but past deal multiples are not reliable benchmarks.

U.S. Equities and the Broad Market

• Galloway described market valuations as elevated: the CAPE ratio was 41, versus a long-run average of about 17. He said it was the second-highest reading in 145 years, behind December 1999.
• Despite those valuations, he argued that CAPE is a poor tool for predicting when a decline will occur: expensive markets can become more expensive before correcting.
• He cited the view that investors who bought on days when stocks reached all-time highs would still have done well, and said that continuing to buy has historically beaten stepping out of the market.
• He warned that recovery can take time: after the 2000 and 2007 downturns, recovery took about four years, and some past decades were essentially flat.
• He recalled selling all his stocks after the 2016 U.S. election in response to political fears. He said the market rose over the following year and that selling and later buying back in cost him substantially, including through taxes and re-entry at higher prices.

Takeaways

• Avoid making all-or-nothing portfolio decisions based on political anxiety or attempts to call a market peak.
• If you continue investing, consider doing so consistently rather than waiting for an ideal entry point; Galloway endorsed staying invested over the medium and long term.
• Elevated valuations may be a reason to review diversification, not necessarily to abandon stocks. The discussion does not establish when a correction will happen or how deep it could be.

Diversification, Concentration, and Leverage

• Galloway said that owning the S&P 500 alone is not necessarily broad diversification, because about 40% of the index was concentrated in a small number of companies.
• He favored diversifying across assets and outside the United States. He acknowledged that his international stocks had performed poorly so far, but said he preferred the diversification and peace of mind.
• He said he was reducing leverage, describing it as a way that “smart people go broke.”
• As a personal approach, he tries not to have more than 5% of his assets in any one thing. He also said he was over-invested in real estate but had no leverage on that real estate, which he felt would help him endure a downturn.
• He described the economy as K-shaped, with wealthier households’ stock-market-linked wealth rising while others’ fortunes were flatter or declining. He suggested this may be an argument for owning productive assets rather than abandoning them.

Takeaways

• Review how much of a portfolio depends on a few large companies, one country, or one asset class.
• Consider whether leverage could make a downturn harder to withstand; Galloway’s stated response was to reduce it.
• His 5% limit is a personal practice, not a universal allocation rule. The broader point is to match concentration and risk to your circumstances.

Portfolio Protection Strategies: Long-Dated Puts and Covered Calls

• As possible ways to seek insurance during a frothy market, Galloway mentioned long-dated puts and covered calls against existing positions.
• He characterized these as more sophisticated approaches and did not provide specific contract terms, prices, or recommendations.

Takeaways

• These strategies were mentioned as possibilities, not as a prescription. Understand how they work and what trade-offs they involve before using them.

Real Estate

• Galloway said he was over-invested in real estate but had no leverage on those holdings, which he believed would let him withstand a down cycle.
• He did not give a real estate price outlook or recommend a particular property or market.

Takeaways

• Consider both the concentration of real estate in your overall assets and the debt attached to it. Galloway emphasized being able to withstand a downturn without leverage.

Biopharmaceuticals and Biotechnology

• In discussing a possible move from Sweden to the United States, Galloway described the U.S. as having a larger life-sciences market and potentially greater financial upside, including through stock options in private-equity-backed pharmaceutical businesses.
• He cited U.S. biopharmaceutical companies’ $96 billion in R&D spending in 2023 and said the U.S. is a global leader in research and development.
• He also described Sweden as having a significant life-sciences sector, accounting for about 10% of the country’s exports.
• Pfizer, Merck, and Gilead were mentioned as examples of potential employers in the hypothetical career discussion—not as stock recommendations.

Takeaways

• The discussion points to the U.S. life-sciences sector as a potentially larger career and equity-compensation opportunity, particularly for highly qualified workers.
• It does not provide a view on the investment merits, valuation, or prospects of any named pharmaceutical company.

Selling a Private Business

• Galloway advised a small-business owner considering a sale that buyer interest in the company’s strategic position and future growth may translate into a higher valuation if there are competing bidders.
• He recommended considering a banker or deal attorney, preparing a strong data room and sales materials, and reaching out truthfully to other potential buyers where possible.
• He emphasized not turning negotiations into a win-lose contest and maintaining a credible willingness to walk away.
• He said valuations across sectors seemed lofty, making it a good time to be a seller. As an example from his own experience, he said his company L2 was ultimately acquired for eight times revenue; he presented this as a historical example, not a comparable valuation target for other businesses.

Takeaways

• For owners weighing a sale, test whether there is interest from more than one credible buyer and make the business’s strategic value clear.
• Treat the eight-times-revenue figure as a past deal example, not a valuation benchmark. Actual value depends on the buyer and seller’s willingness to transact.